BioStem Technologies, Inc. BSEM
1.04 USD -0.12 (-10.34%)
At closeNov 5, 2026, 4:03 PM EST
1.05 +0.01 +0.96%
After hours · Nov 5, 4:03 PM ET
1.01 Day range 1.17
1.01 52-week range 8.40
- YTD
- -72.70%
- 1 year
- -74.63%
- Market cap
- 19.42M
- EPS (ttm)
- 0.88
- P/E ratio
- 1.18
- YTD return
- -72.70%
- 1-year return
- -74.63%
- Volume
- 197.14K
- Avg volume
- 160.13K
- Open
- 1.17
- Previous close
- 1.16
- Day's range
- 1.01 – 1.17
- 52-week range
- 1.01 – 8.40
- Earnings date
- Aug 12, 2024
5D -0.23 (-18.11%)
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate 0.12.
Financials — quick view
BSEM Revenue — quarterly 7.90M
BSEM Net income — quarterly -8.97M
BSEM EPS — quarterly -0.52
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.31 | 0.32 | +0.01 | +3.23% |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | 0.30 | +0.18 | +150.00% |
| May 14, 2024 | Mar 1, 2024 | 0.74 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.74 | 0.20 | -0.54 | -72.97% |
| Apr 1, 2024 | Dec 1, 2023 | 0.47 | — | — | — |
News
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026 
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options 
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options 
Century Therapeutics (NASDAQ:IPSC) and BioStem Technologies (OTCMKTS:BSEM) Financial Analysis 
BioStem Secures US Patent, Additional US And Mexico Allowances For Tissue Technologies 
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio 
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio 
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules 
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules 
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
Your note
Sign in to keep a note on BSEM — it syncs with the Stock Master app.